Temporary exacerbation of pre-existing psoriasis and eczema in the context of COVID-19 messenger RNA booster vaccination: A case report and review of the literature

被引:9
作者
Phuan, Crystal Zhen Yu [1 ]
Choi, Ellie Ci-En [1 ]
Oon, Hazel H. [1 ,2 ]
机构
[1] Natl Skin Ctr, Div Dermatol, Singapore, Singapore
[2] Natl Skin Ctr, Mandalay Rd, Singapore 308205, Singapore
来源
JAAD INTERNATIONAL | 2022年 / 6卷
关键词
booster; COVID-19; drugs; eczema; immunosuppression; psoriasis; rashes; vaccination;
D O I
10.1016/j.jdin.2021.11.004
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:94 / 96
页数:3
相关论文
共 5 条
[1]  
[Anonymous], Pfizer and BioNTech Initiate Phase 1 Study of Single Dose mRNA-Based Combination Vaccine Candidate for Influenza and COVID-19
[2]  
[Anonymous], 2019, CAUSALITY ASSESSMENT, V2nd
[3]  
[Anonymous], Coronavirus en Colombia
[4]   Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021 [J].
Hause, Anne M. ;
Baggs, James ;
Gee, Julianne ;
Marquez, Paige ;
Myers, Tanya R. ;
Shimabukuro, Tom T. ;
Shay, David K. .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (39) :1379-1384
[5]   Dermatology patients on biologics and certain other systemic therapies should receive a "booster'' messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations [J].
Waldman, Reid Alexander ;
Grant-Kels, Jane M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (05) :1113-1116